HDAC9 and acute myeloid leukemia: Ling and colleagues found that HDAC9 expression was necessary for MLLr AML cell proliferation and that the combination of venetoclax and MI-503 repressed HIF1α expression, which in turn inhibited the transcription of HDAC9 [190].